Biphenotypic (hepatobiliary) Primary Liver Carcinomas: the Work in Progress

Overview

Journal Hepat Oncol

Date 2018 Sep 8

PMID 30191007

Citations 15

Authors

Elizabeth M Brunt

Valerie Paradis

Christine Sempoux

Neil D Theise

Affiliations

Soon will be listed here.

Abstract

Recent WHO classification for combined hepatocellular-cholangiocarcinoma and recognized stem cell subtypes has increased attention to such tumors; however, the resulting burst of reporting and research indicates that this classification, while provocative, is incomplete for description of the full array of primary liver carcinomas with biphenotypic (hepatobiliary) differentiation. We review the history of such lesions and consider the wider array of such tumors previously described. Mixed hepatobiliary phenotypes and immunophenotypes are found in individual tumors at the tissue level - with architectural and cytologic features supportive of both differentiation states - and at the cellular level, with individual cells that display cytology of one cell type, but immunophenotypically showing mixed expression. Pathobiologic and clinical questions to be answered by future research are suggested.

Citing Articles

Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies.

Gurzu S, Szodorai R, Jung I, Banias L J Cancer Res Clin Oncol. 2024; 150(5):270.

PMID: 38780656 PMC: 11116183. DOI: 10.1007/s00432-024-05781-8.

Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.

Zhu Y, Tang S, Yuan Q, Fu J, He J, Liu Z Cell Rep Med. 2024; 5(2):101375.

PMID: 38278146 PMC: 10897507. DOI: 10.1016/j.xcrm.2023.101375.

Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach.

Choi J, Ro J Biomedicines. 2022; 10(8).

PMID: 36009374 PMC: 9405224. DOI: 10.3390/biomedicines10081826.

Decreased ARG1 expression as an adverse prognostic phenotype in non-alcoholic non-virus-related hepatocellular carcinoma.

Shigematsu Y, Amori G, Kanda H, Takahashi Y, Takazawa Y, Takeuchi K Virchows Arch. 2022; 481(2):253-263.

PMID: 35459975 DOI: 10.1007/s00428-022-03318-3.

Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma.

Azizi A, Hadjinicolaou A, Goncalves C, Duckworth A, Basu B Front Oncol. 2020; 10:570958.

PMID: 33102226 PMC: 7545907. DOI: 10.3389/fonc.2020.570958.

References

Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang H . EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology. 2009; 136(3):1012-24. PMC: 2828822. DOI: 10.1053/j.gastro.2008.12.004. View

Kuwahara R, Kofman A, Landis C, Swenson E, Barendswaard E, Theise N . The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology. 2008; 47(6):1994-2002. PMC: 2847183. DOI: 10.1002/hep.22218. View

Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H . Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003; 94(10):851-7. PMC: 11160230. DOI: 10.1111/j.1349-7006.2003.tb01366.x. View

Theise N, Yao J, Harada K, Hytiroglou P, Portmann B, Thung S . Hepatic 'stem cell' malignancies in adults: four cases. Histopathology. 2003; 43(3):263-71. DOI: 10.1046/j.1365-2559.2003.01707.x. View

DErrico A, Baccarini P, Fiorentino M, Ceccarelli C, Bonazzi C, Ponzetto A . Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Pathol. 1996; 27(6):599-604. DOI: 10.1016/s0046-8177(96)90169-0. View

Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J . The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology. 2006; 49(2):138-51. DOI: 10.1111/j.1365-2559.2006.02468.x. View

Holczbauer A, Factor V, Andersen J, Marquardt J, Kleiner D, Raggi C . Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology. 2013; 145(1):221-231. PMC: 3913051. DOI: 10.1053/j.gastro.2013.03.013. View

Tickoo S, Zee S, Obiekwe S, Xiao H, Koea J, Robiou C . Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol. 2002; 26(8):989-97. DOI: 10.1097/00000478-200208000-00003. View

Sempoux C, Fan C, Singh P, Obeidat K, Roayaie S, Schwartz M . Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis. 2011; 31(1):104-10. DOI: 10.1055/s-0031-1272838. View

10.

Govaere O, Komuta M, Berkers J, Spee B, Janssen C, De Luca F . Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. 2013; 63(4):674-85. PMC: 3963546. DOI: 10.1136/gutjnl-2012-304351. View

11.

Zucman-Rossi J, Nault J, Zender L . Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis. Gastroenterology. 2013; 145(1):53-55. DOI: 10.1053/j.gastro.2013.05.024. View

12.

Nakanuma Y, Xu J, Harada K, Sato Y, Sasaki M, Ikeda H . Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases. Pathol Int. 2011; 61(5):298-305. DOI: 10.1111/j.1440-1827.2011.02665.x. View

13.

Singh S, Chakraborty S, Bonthu N, Radio S, Hussain S, Sasson A . Combined hepatocellular cholangiocarcinoma: a case report and review of literature. Dig Dis Sci. 2013; 58(7):2114-23. DOI: 10.1007/s10620-013-2585-1. View

14.

Ariizumi S, Kotera Y, Katagiri S, Nakano M, Nakanuma Y, Saito A . Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy. Ann Surg Oncol. 2014; 21 Suppl 3:S451-8. PMC: 4024138. DOI: 10.1245/s10434-014-3582-0. View

15.

Goodman Z, Ishak K, Langloss J, Sesterhenn I, Rabin L . Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985; 55(1):124-35. DOI: 10.1002/1097-0142(19850101)55:1<124::aid-cncr2820550120>3.0.co;2-z. View

16.

Komuta M, Spee B, Vander Borght S, De Vos R, Verslype C, Aerts R . Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008; 47(5):1544-56. DOI: 10.1002/hep.22238. View

17.

Falkowski O, An H, Ianus I, Chiriboga L, Yee H, West A . Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J Hepatol. 2003; 39(3):357-64. DOI: 10.1016/s0168-8278(03)00309-x. View

18.

Akiba J, Nakashima O, Hattori S, Tanikawa K, Takenaka M, Nakayama M . Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol. 2013; 37(4):496-505. DOI: 10.1097/PAS.0b013e31827332b0. View

19.

Kleihues P, Sobin L . World Health Organization classification of tumors. Cancer. 2000; 88(12):2887. DOI: 10.1002/1097-0142(20000615)88:12<2887::aid-cncr32>3.0.co;2-f. View

20.

Shiota K, Taguchi J, Nakashima O, Nakashima M, Kojiro M . Clinicopathologic study on cholangiolocellular carcinoma. Oncol Rep. 2001; 8(2):263-8. View